Lambert drug-promotion charge
Marketing executives at Warner-Lambert Co. urged their superiors to let them promote the epilepsy drug Neurontin for the an unapproved use rather than perform the clinical studies needed to prove the
Marketing executives at Warner-Lambert Co. urged their superiors to let them promote the epilepsy drug Neurontin for the an unapproved use rather than perform the clinical studies needed to prove the